Latest Xenon Stories

VANCOUVER, British Columbia, April 22, 2013 /PRNewswire/ -- Xenon Pharmaceuticals Inc. is pleased to announce that it has been awarded BIOTECanada's Gold Leaf Company of the Year Award for 2013. The prestigious Gold Leaf Awards ceremony will take place on Tuesday, April 23 at the BIO International Convention in Chicago. Several thousand guests will be in attendance, representing the global life sciences community. "We are honored to be recognized by our national industry peers...

VANCOUVER, British Columbia, April 17, 2013 /PRNewswire/ -- Xenon announced that Merck, known as MSD outside the United States and Canada, through an affiliate, has exercised its option to exclusively license small molecule compounds for a novel target for the potential treatment of cardiovascular disease. In 2009, Xenon and Merck entered into a strategic alliance where Xenon employed its human clinical genetics platform to validate novel cardiovascular targets and collaborated on the...

VANCOUVER, Canada, April 8, 2013 /PRNewswire/ -- Xenon Pharmaceuticals Inc. is pleased to announce that it has been awarded the LifeSciences British Columbia Life Sciences Company of the Year Award for 2013. (Photo: http://photos.prnewswire.com/prnh/20130408/SF89970) The LifeSciences British Columbia Awards took take place on Thursday, April 4 at the Vancouver Convention Centre with several hundred guests representing the British Columbia life sciences community. "We are...

VANCOUVER, British Columbia, Feb. 13, 2013 /PRNewswire/ -- Xenon Pharmaceuticals Inc. is pleased to announce the appointment of Gary J. Bridger PhD as Executive Vice President, Research and Development. "We are delighted to welcome Gary to the Xenon team," commented Simon Pimstone, Xenon's President and CEO. "As a co-founder and CSO of AnorMED, he was responsible for the development of MOZOBIL, a hematopoietic stem cell mobilizing agent for non-Hodgkin's lymphoma and multiple...

VANCOUVER, British Columbia, Feb. 5, 2013 /PRNewswire/ -- Xenon, a clinical stage biopharmaceutical company developing novel therapeutics for rare diseases, today announced that it has received a milestone payment from uniQure BV for the European Commission marketing approval of Glybera®, a novel gene therapy treatment for the orphan disease lipoprotein lipase deficiency (LPLD), and the first gene therapy approved in the Western world. Xenon exclusively licensed to uniQure BV its...

April Flowers for redOrbit.com - Your Universe Online Nearly a mile underground beneath the Black Hills of South Dakota, scientists from Lawrence Livermore National Laboratory (LLNL) are using a tank to make key contributions to a physics experiment that will look for one of nature's most elusive particles, "dark matter." The Large Underground Xenon (LUX) experiment located at the Sanford Underground Research Facility in Lead, SD is the most sensitive detector of its kind to look for...

Brett Smith for redOrbit.com - Your Universe Online An international team of researchers has created ionized xenon atoms so positively charged that scientists involved in the study are now saying the existing theories need to be reexamined. Using the world’s most powerful laser, the Linac Coherent Light Source (LCLS) at the U.S. Department of Energy's (DOE) SLAC National Accelerator Laboratory at Stanford University, the physicists were able to kick out up to 36 electrons from a xenon...

Pocar, Kumar and the team of 60 scientists using an instrument called the EXO-200 detector, succeeded in setting a new lower limit for the half-life of this ephemeral nuclear decay; though no one has yet seen it, important progress was made Physicists Andrea Pocar and Krishna Kumar of the University of Massachusetts Amherst, part of an international research team, recently reported results of an experiment conducted at the Enriched Xenon Observatory (EXO), located in a salt mine one-half...

Scientists from the XENON collaboration announced a new result from their search for dark matter. The analysis of data taken with the XENON100 detector during 13 months of operation at the Gran Sasso Laboratory (Italy) provided no evidence for the existence of Weakly Interacting Massive Particles (WIMPs), the leading dark matter candidates. Two events being observed are statistically consistent with one expected event from background radiation. Compared to their previous 2011 result the...

Key experiment in nuclear physics Stable tin, as we know it, comprises 112 nuclear particles – 50 protons and 632 neutrons. The neutrons act as a kind of buffer between the electrically repelling protons and prevent normal tin from decaying. According to the shell model of nuclear physics, 50 is a "magic number" that gives rise to special properties. Tin-100, with 50 protons and 50 neutrons, is "doubly magic," making it particularly interesting for nuclear physicists. Shooting...